The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Abstract
Engineering human IgG1 Fc binding to a brain endothelial cell–enriched receptor allows enhanced brain exposure of biotherapeutics in multiple species.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[19] Rapid and efficient site-specific mutagenesis without phenotypic selection
Kunkel, T. A., Roberts, J. D., & Zakour, R. A. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)54085-x · Cited by 5,261
Daneman, R., & Prat, A. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020412 · Cited by 3,437
Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
Development of therapeutic antibodies for the treatment of diseases
Lu, R.-M., Hwang, Y.-C., Liu, I.-J., Lee, C.-C., Tsai, H.-Z., Li, H.-J., & Wu, H.-C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0592-z · Cited by 2,085
Maxfield, F. R., & McGraw, T. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1315 · Cited by 1,729
Transferrin receptor on endothelium of brain capillaries
Jefferies, W. A., Brandon, M. R., Hunt, S. V., Williams, A. F., Gatter, K. C., & Mason, D. Y. (1984) · Nature · doi:10.1038/312162a0 · Cited by 1,061
The role of brain vasculature in neurodegenerative disorders
Sweeney, M. D., Kisler, K., Montagne, A., Toga, A. W., & Zlokovic, B. V. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0234-x · Cited by 998
Isolating and engineering human antibodies using yeast surface display
Chao, G., Lau, W. L., Hackel, B. J., Sazinsky, S. L., Lippow, S. M., & Wittrup, K. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.94 · Cited by 909
Boosting Brain Uptake of a Therapeutic Antibody by Reducing Its Affinity for a Transcytosis Target
Yu, Y. J., Zhang, Y., Kenrick, M., Hoyte, K., Luk, W., Lu, Y., Atwal, J., Elliott, J. M., Prabhu, S., Watts, R. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002230 · Cited by 794
Self-citationProteopathic tau seeding predicts tauopathy in vivo
Holmes, B. B., Furman, J. L., Mahan, T. E., Yamasaki, T. R., Mirbaha, H., Eades, W. C., Belaygorod, L., Cairns, N. J., Holtzman, D. M., & Diamond, M. I. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411649111 · Cited by 696
An overview of APP processing enzymes and products.
Chow, V. W., Mattson, M. P., Wong, P. C., & Gleichmann, M. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8104-z · Cited by 684
Niewoehner, J., Bohrmann, B., Collin, L., Urich, E., Sade, H., Maier, P., Rueger, P., Stracke, J. O., Lau, W., Tissot, A. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2013.10.061 · Cited by 622
The role of brain barriers in fluid movement in the CNS: is there a ‘glymphatic’ system?
Abbott, N. J., Pizzo, M. E., Preston, J. E., Janigro, D., & Thorne, R. G. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1812-4 · Cited by 593
Self-citationEngaging neuroscience to advance translational research in brain barrier biology
Neuwelt, E. A., Bauer, B., Fahlke, C., Fricker, G., Iadecola, C., Janigro, D., Leybaert, L., Molnár, Z., O'Donnell, M. E., Povlishock, J. T., et al. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2995 · Cited by 579
Self-citationBrain barriers: Crosstalk between complex tight junctions and adherens junctions
Tietz, S., & Engelhardt, B. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412147 · Cited by 551
Blood–Brain Barrier Transport of Therapeutics via Receptor-Mediation
Jones, A. R., & Shusta, E. V. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9379-0 · Cited by 549
Receptor‐mediated transcytosis of transferrin across the blood‐brain barrier
Fishman, J. B., Rubin, J. B., Handrahan, J. V., Connor, J. R., & Fine, R. E. (1987) · Journal of Neuroscience Research · doi:10.1002/jnr.490180206 · Cited by 544
An efficient route to human bispecific IgG
Merchant, A. M., Zhu, Z., Yuan, J. Q., Goddard, A., Adams, C. W., Presta, L. G., & Carter, P. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-677 · Cited by 510
Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain
Patel, M. M., & Patel, B. M. (2017) · CNS Drugs · doi:10.1007/s40263-016-0405-9 · Cited by 430
Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.
Friden, P. M., Walus, L. R., Musso, G. F., Taylor, M. A., Malfroy, B., & Starzyk, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4771 · Cited by 402
Protein size and cerebrospinal fluid composition
Felgenhauer, K. (1974) · Klinische Wochenschrift · doi:10.1007/bf01466734 · Cited by 396
Transferrin and Transferrin Receptor Function in Brain Barrier Systems
Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394
The Molecular Constituents of the Blood–Brain Barrier
Chow, B. W., & Gu, C. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.003 · Cited by 380
Macromolecular permeability across the blood-nerve and blood-brain barriers.
Poduslo, J. F., Curran, G. L., & Berg, C. T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5705 · Cited by 377
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
Yu, Y. J., Atwal, J. K., Zhang, Y., Tong, R. K., Wildsmith, K. R., Tan, C., Bien-Ly, N., Hersom, M., Maloney, J. A., Meilandt, W. J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009835 · Cited by 371
Self-citationHuman blood-brain barrier transferrin receptor
Pardridge, W. M., Eisenberg, J., & Yang, J. (1987) · Metabolism · doi:10.1016/0026-0495(87)90099-0 · Cited by 356
Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants
Bien-Ly, N., Yu, Y. J., Bumbaca, D., Elstrott, J., Boswell, C. A., Zhang, Y., Luk, W., Lu, Y., Dennis, M. S., Weimer, R. M., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131660 · Cited by 353
Self-citationEffector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
Lo, M., Kim, H. S., Tong, R. K., Bainbridge, T. W., Vernes, J.-M., Zhang, Y., Lin, Y. L., Chung, S., Dennis, M. S., Zuchero, Y. J. Y., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.767749 · Cited by 323
Self-citationPestalozzi, B. C., & Brignoli, S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2349 · Cited by 301
Diffusion of Macromolecules in the Brain: Implications for Drug Delivery
Wolak, D. J., & Thorne, R. G. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300495e · Cited by 299
Self-citationHezareh, M., Hessell, A. J., Jensen, R. C., van de Winkel, J. G. J., & Parren, P. W. H. I. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12161-12168.2001 · Cited by 294
Lee, H. J., Engelhardt, B., Lesley, J., Bickel, U., & Pardridge, W. M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35388-1 · Cited by 287
A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-β Production in Vivo
Atwal, J. K., Chen, Y., Chiu, C., Mortensen, D. L., Meilandt, W. J., Liu, Y., Heise, C. E., Hoyte, K., Luk, W., Lu, Y., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002254 · Cited by 274
Self-citationPizzo, M. E., Wolak, D. J., Kumar, N. N., Brunette, E., Brunnquell, C. L., Hannocks, M., Abbott, N. J., Meyerand, M. E., Sorokin, L., Stanimirovic, D. B., et al. (2018) · The Journal of Physiology · doi:10.1113/jp275105 · Cited by 272
Self-citationAddressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Couch, J. A., Yu, Y. J., Zhang, Y., Tarrant, J. M., Fuji, R. N., Meilandt, W. J., Solanoy, H., Tong, R. K., Hoyte, K., Luk, W., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005338 · Cited by 268
Self-citationThe neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
Sockolosky, J. T., & Szoka, F. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.02.005 · Cited by 235
Developing Therapeutic Antibodies for Neurodegenerative Disease
Yu, Y. J., & Watts, R. J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0187-4 · Cited by 227
Self-citationUllman, J. C., Arguello, A., Getz, J. A., Bhalla, A., Mahon, C. S., Wang, J., Giese, T., Bedard, C., Kim, D. J., Blumenfeld, J. R., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1163 · Cited by 205
Self-citationBoado, R. J., Zhang, Y., Zhang, Y., & Pardridge, W. M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21120 · Cited by 203
Self-citationSonoda, H., Morimoto, H., Yoden, E., Koshimura, Y., Kinoshita, M., Golovina, G., Takagi, H., Yamamoto, R., Minami, K., Mizoguchi, A., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.032 · Cited by 197
Stefanacci, L., SUZUKI, W. A., & Amaral, D. G. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961125)375:4<675::aid-cne8>3.0.co;2-z · Cited by 193
St-Amour, I., Paré, I., Alata, W., Coulombe, K., Ringuette-Goulet, C., Drouin-Ouellet, J., Vandal, M., Soulet, D., Bazin, R., & Calon, F. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.160 · Cited by 191
Wozniak‐Knopp, G., Bartl, S., Bauer, A., Mostageer, M., Woisetschläger, M., Antes, B., Ettl, K., Kainer, M. A., Weberhofer, G., Wiederkum, S., et al. (2010) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq005 · Cited by 126
Kordower, J. H., Charles, V., Bayer, R. A., Bartus, R. T., Putney, S. D., Walus, L. R., & Friden, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9077 · Cited by 116
Ajioka, R. S., & Kaplan, J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6445 · Cited by 98
Ackerman, M. E., Levary, D. A., Tobon, G., Hackel, B. J., Orcutt, K. D., & Wittrup, K. D. (2009) · Biotechnology Progress · doi:10.1002/btpr.174 · Cited by 93
Open questions for Alzheimer’s disease immunotherapy
Golde, T. E. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt233 · Cited by 89
Recent Advances in Delivery Through the Blood-Brain Barrier
Larsen, J., Martin, D. R., & Byrne, M. E. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140329230311 · Cited by 87
Macromolecular drug transport into the brain using targeted therapy
Lichota, J., Skjørringe, T., Thomsen, L. B., & Moos, T. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06544.x · Cited by 81
Thom, G., Burrell, M. R., Haqqani, A. S., Yogi, Á., Lessard, E., Brunette, E., Delaney, C. E., Baumann, E., Callaghan, D., Melero, N. R., et al. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00937 · Cited by 76
Kumar, N. N., Pizzo, M. E., Nehra, G., Wilken-Resman, B., Boroumand, S., & Thorne, R. G. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00548 · Cited by 69
Self-citationWebster, C. I., Hatcher, J. P., Burrell, M. R., Thom, G., Thornton, P., Gurrell, I. K., & Chessell, I. P. (2016) · Pain · doi:10.1097/j.pain.0000000000000810 · Cited by 67
Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration
Hanzatian, D. K., Schwartz, A. J., Gizatullin, F., Erickson, J., Deng, K., Villanueva, R., Stedman, C., Harris, C., Ghayur, T., & Goodearl, A. D. J. (2018) · mAbs · doi:10.1080/19420862.2018.1465159 · Cited by 56
Engineered IgG1‐Fc – one fragment to bind them all
Laurent, E., Traxlmayr, M. W., Obinger, C., & Hasenhindl, C. (2016) · Immunological Reviews · doi:10.1111/imr.12385 · Cited by 50
Current advances in delivery of biotherapeutics across the blood-brain barrier.
Rajadhyaksha, M., Boyden, T., Liras, J., El-Kattan, A., & Brodfuehrer, J. (2011) · Current Drug Discovery Technologies · doi:10.2174/157016311795563866 · Cited by 49
Yadav, D. B., Maloney, J. A., Wildsmith, K. R., Fuji, R. N., Meilandt, W. J., Solanoy, H., Lu, Y., Peng, K., Wilson, B., Chan, P., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14021 · Cited by 49
Self-citationHammarlund‐Udenaes, M., Thorne, R. G., & de Lange, E. C. M. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7 · Cited by 44
Self-citationEngineered Fc based antibody domains and fragments as novel scaffolds
Ying, T., Gong, R., Ju, T. W., Prabakaran, P., & Dimitrov, D. S. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2014.04.018 · Cited by 40
Friden, P. M., Olson, T. S., Obar, R. A., Walus, L. R., & Putney, S. D. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20804-7 · Cited by 39
Leung, K.-M., Batey, S., Rowlands, R. J., Isaac, S. J., Jones, P. C., Drewett, V., Carvalho, J., Gaspar, M. A., Weller, S., Medcalf, M., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.127 · Cited by 36
Engineering of binding functions into proteins
Gebauer, M., & Skerra, A. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.05.007 · Cited by 35
Everett, K. L., Kraman, M., Wollerton, F., Zimarino, C., Kmiecik, K., Gaspar, M., Pechouckova, S., Allen, N. L., Doody, J. F., & Tuna, M. (2018) · Methods · doi:10.1016/j.ymeth.2018.09.003 · Cited by 31
Traxlmayr, M. W., Wozniak‐Knopp, G., Antes, B., Stadlmayr, G., Rüker, F., & Obinger, C. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.06.042 · Cited by 22
Cited by
Strategies for delivering therapeutics across the blood–brain barrier
Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138
Mead, R. J., Shan, N., Reiser, H. J., Marshall, F., & Shaw, P. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00612-2 · Cited by 505
Fundamental Biological Features of Spaceflight: Advancing the Field to Enable Deep-Space Exploration
Afshinnekoo, E., Scott, R. T., MacKay, M. J., Pariset, E., Cekanaviciute, E., Barker, R., Gilroy, S., Hassane, D., Smith, S. M., Zwart, S. R., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.050 · Cited by 478
Drug delivery to the central nervous system
Nance, E., Pun, S. H., Saigal, R., & Sellers, D. L. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00394-w · Cited by 414
Engineering protein-based therapeutics through structural and chemical design
Ebrahimi, S. B., & Samanta, D. (2023) · Nature Communications · doi:10.1038/s41467-023-38039-x · Cited by 382
Metadata
- Authors
- Kariolis, M. S., Wells, R. C., Getz, J. A., Kwan, W., Mahon, C. S., Tong, R., Kim, D. J., Srivastava, A., Bedard, C., Henne, K. R., Giese, T., Assimon, V. A., Chen, X., Zhang, Y., Solanoy, H., Jenkins, K., Sanchez, P. E., Kane, L., Miyamoto, T., Chew, K. S., Pizzo, M. E., Liang, N., Calvert, M. E. K., DeVos, S. L., Baskaran, S., Hall, S., Sweeney, Z. K., Thorne, R. G., Watts, R. J., Dennis, M. S., Silverman, A. P., & Zuchero, Y. J. Y.
- Venue
- Science Translational Medicine
- Published
- 2020-05-27
- Volume
- 12
- Issue
- 545
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3032843652
- Cited by
- 349
- References
- 64
- FWCI
- 14.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.